Explore our core biopharmaceutical services and extraction research capabilities, engineered to elevate natural compound purity to certified international standards.
Moving beyond crude extraction toward targeted molecular purification and consistent pharmacologically active isolate delivery.
We deploy specialized cross-linked polyaromatic and acrylic adsorbents tailored specifically for selective reversible adsorption. This permits the continuous concentration of targeted polyphenols, triterpenoid saponins, and flavonoids while rejecting unbound ballast sugars, proteins, and minerals.
For high-value monomeric therapeutics requiring assay purity levels of 98% to 99.5%, our facility utilizes industrial-scale DAC (Dynamic Axial Compression) chromatography columns. High theoretical plate counts deliver sharp baseline separation of diastereomers and near-isobaric impurities.
Green chemistry isolation using state-of-the-art dense-phase carbon dioxide extraction eliminates carcinogenic residual solvents. Fractionation controls volatile essential oils and lipophilic bioactives under gentle, oxygen-free thermodynamic envelopes.
Addressing the shifting landscape of botanical procurement, where purity certification, ESG transparency, and impurity thresholds govern supply agreements.
Global brands no longer accept batch-to-batch content drift. Procurement contracts require comprehensive HPLC/UPLC and HPTLC chromatographic chemical profiling to demonstrate identical secondary metabolite matrices across commercial supply lots.
International compliance demands absolute removal of environmental residues. Our purification trains integrate tailored molecular sieves, membrane nanofiltration, and enzymatic scrubbing to guarantee zero polycyclic aromatic hydrocarbons (PAHs), heavy metals, or pesticide drift.
Enterprises require clear documentation from geo-authentic botanical origin through industrial purification. Yineng Pharma maintains complete traceability matrices back to verified GAP wild-harvest or cultivated bases, guaranteeing verifiable sustainability credentials.
A closed-loop, GMP-aligned technical methodology engineered to handle complex botanical raw materials from lab discovery to industrial purification.
Evaluation of potency based on plant part, harvest seasonality, and geographic terroir to maximize raw precursor compound concentrations prior to processing.
Ultrasonic-assisted, microwave-assisted, or pressurized solvent countercurrent extraction systems configured to maximize mass-transfer rates while preventing thermal degradation.
Ceramic microfiltration and polymeric ultrafiltration cascades systematically eliminate pectins, starches, and cellular debris, delivering clear permeates directly to column resins.
Solvent crystallization and vacuum freeze-drying yield highly stable crystalline powders, micronized isolates, or purified extracts with strictly controlled polymorphic structure.
Overcoming jurisdictional regulatory hurdles through empirical documentation, validated analytical procedures, and dedicated tech-transfer teams.
Every purified batch is certified against specific compendial monographs. We provide fully validated testing methodologies, complete HPLC chromatograms, NMR structure elucidations, and ICP-MS elemental impurity profiles.
Working under strict non-disclosure legal covenants within our entrusted CDMO framework, client intellectual property, novel extraction fractions, and proprietary excipient matrices remain shielded from unauthorized exposure.
Comprehensive regulatory dossier construction, including DMF (Drug Master File) components, stability testing under ICH conditions, and dedicated logistical monitoring for zero cold-chain disruption globally.
Continuous bioprocess innovation: Integrating molecular imprinting, continuous chromatography, and artificial intelligence into botanical downstream isolation.
Industrialization of Simulated Moving Bed (SMB) continuous liquid chromatography, cutting organic solvent consumption by up to 60% while dramatically elevating yield and single-enantiomer purification capabilities.
Engineering synthetic affinity matrices that selectively extract targeted bio-actives from crude herbal decoctions, bypassing multiple labor-intensive intermediate purification passes.
Deploying computational machine-learning algorithms to simulate mobile-phase gradients, predict retention kinetics across novel column stationary phases, and drastically compress scale-up optimization timelines.
Essential guidance for procurement executives, lead scientists, and formulation development teams evaluating purification partners.
Explore our complete spectrum of active ingredient process design, regulatory dossiers, and finished clinical-grade dosage form manufacturing capabilities.
